MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2708.25%
Quick Ratio
2708.25%
Cash Ratio
436.14%
Debt to Asset Ratio
5.24%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right of use ass...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, net o...
    • Others
Balance Sheets
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
78,056
251,359
55,067
Accounts receivable
58
-
-
Short-term investments
398,726
261,667
205,380
Restricted cash
105
105
105
Prepaid expenses and other current assets
7,750
7,528
9,690
Total current assets
484,695
520,659
270,242
Property and equipment, net
2,518
3,116
3,172
Operating lease right of use asset, net
9,327
10,480
11,047
Other assets
1,057
1,068
1,034
Total assets
497,597
535,323
285,495
Accounts payable
6,561
3,235
3,176
Accrued expenses and other current liabilities
8,721
8,599
6,944
Operating lease liability
2,615
2,482
1,759
Total current liabilities
17,897
14,316
11,879
Operating lease liability, net of current portion
8,188
9,390
10,104
Total liabilities
26,085
23,706
21,983
Common stock, 0.001 par value 500,000,000 shares authorized at march 31, 2026 and december 31, 2025 47,807,453 shares and 47,772,567 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
48
48
37
Additional paid-in capital
727,054
712,889
438,091
Accumulated other comprehensive income (loss)
-505
145
-76
Accumulated deficit
-255,085
-201,465
-174,540
Total stockholders' equity
471,512
511,617
263,512
Total liabilities and stockholders' equity
497,597
535,323
285,495
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$398,726K Cash and cashequivalents$78,056K Prepaid expenses andother current assets$7,750K Restricted cash$105K Accounts receivable$58K Total current assets$484,695K Operating lease right ofuse asset, net$9,327K Property and equipment,net$2,518K Other assets$1,057K Total assets$497,597K Total liabilities andstockholders' equity$497,597K Total stockholders'equity$471,512K Total liabilities$26,085K Accumulated deficit-$255,085K Accumulated othercomprehensive income (loss)-$505K Additional paid-in capital$727,054K Total currentliabilities$17,897K Operating leaseliability, net of current...$8,188K Common stock, 0.001 parvalue 500,000,000...$48K Accrued expenses andother current...$8,721K Accounts payable$6,561K Operating lease liability$2,615K

Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. (RAPP)